IL4R and neoplasm: As the experimental studies demonstrated that genetic deletion of IL-4Rα is associated with increased tumour initiation, but not accelerated tumour growth, we tested whether altered IL-4Rα-mediated signalling would be associated with increased CRC risk, but a differential effect on CRC outcomes after diagnosis, in a case–control epidemiological study.